Clinical Trials Browser

Phase 1 × INDUSTRY × nelarabine × Clear all

NCT00406757 2017-11-13

Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or Lymphoma

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma